Improving drug safety: From adverse drug reaction knowledge discovery to clinical implementation
Authors:
Abstract
No abstract availableKeywords
Funding Information
- Guangdong Innovative and Entrepreneurial Research Team Program (201301S0105240297)
- Major International Joint Research Program of China (31420103901)
- National Science Foundation of China (71271061, 70801020)
- Science and Technology Planning Project of Guangdong Province, China (2010B010600034, 2012B091100192)
- National Science Foundation
This publication has 121 references indexed in Scilit:
- Drug target prediction using adverse event report systems: a pharmacogenomic approachBioinformatics, 2012
- Drug-target network in myocardial infarction reveals multiple side effects of unrelated drugsScientific Reports, 2011
- Detecting Drug Interactions From Adverse-Event Reports: Interaction Between Paroxetine and Pravastatin Increases Blood Glucose LevelsClinical Pharmacology & Therapeutics, 2011
- Selecting information in electronic health records for knowledge acquisitionJournal of Biomedical Informatics, 2010
- Association of Cytochrome P450 2C19 Genotype With the Antiplatelet Effect and Clinical Efficacy of Clopidogrel TherapyJAMA, 2009
- Prediction of drug–target interaction networks from the integration of chemical and genomic spacesBioinformatics, 2008
- GLIDA: GPCR ligand database for chemical genomics drug discovery database and tools updateNucleic Acids Research, 2007
- Identifying genetic risk factors for serious adverse drug reactions: current progress and challengesNature Reviews Drug Discovery, 2007
- How many drug targets are there?Nature Reviews Drug Discovery, 2006
- The Protein Data BankNucleic Acids Research, 2000